Clinical Trials Directory

Trials / Unknown

UnknownNCT04178135

Recombinant LH Supplementation Timing Strategies (From Day 1 or Day 6) to a Standard GnRH Agonist Long Protocol in Subsequent COS Cycle of Older Patients With Unexpected Poor or Suboptimal Ovarian Response

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Reproductive & Genetic Hospital of CITIC-Xiangya · Academic / Other
Sex
Female
Age
35 Months – 40 Years
Healthy volunteers
Accepted

Summary

A randomized, controlled, pilot study, for Patients ≥ 35 years and \< 40 years old with sufficient ovarian reserve parameters (AFC≥ 5), but showed an unexpected poor or suboptimal ovarian response(defined as ≤ 9 retrieved oocytes in previous full-stimulation cycle, but not get live birth after all embryos were used ). In order to get better oocyte number and quality in the new COS cycle, we will compare LH supplementation from beginning with from middle of stimulation in GnRH-a long protocol.

Conditions

Interventions

TypeNameDescription
DRUGrLHrLH supplement from day 1 of stimulation
DRUGrLHrLH supplement from day 6 of stimulation

Timeline

Start date
2019-12-25
Primary completion
2022-12-30
Completion
2022-12-30
First posted
2019-11-26
Last updated
2022-01-11

Locations

2 sites across 1 country: China

Source: ClinicalTrials.gov record NCT04178135. Inclusion in this directory is not an endorsement.